1. Home
  2. PRPL vs ANVS Comparison

PRPL vs ANVS Comparison

Compare PRPL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPL
  • ANVS
  • Stock Information
  • Founded
  • PRPL 2010
  • ANVS 2008
  • Country
  • PRPL United States
  • ANVS United States
  • Employees
  • PRPL N/A
  • ANVS N/A
  • Industry
  • PRPL Home Furnishings
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPL Consumer Discretionary
  • ANVS Health Care
  • Exchange
  • PRPL Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • PRPL 90.3M
  • ANVS 92.6M
  • IPO Year
  • PRPL N/A
  • ANVS 2020
  • Fundamental
  • Price
  • PRPL $1.03
  • ANVS $2.60
  • Analyst Decision
  • PRPL Buy
  • ANVS Strong Buy
  • Analyst Count
  • PRPL 3
  • ANVS 6
  • Target Price
  • PRPL $1.70
  • ANVS $31.40
  • AVG Volume (30 Days)
  • PRPL 551.3K
  • ANVS 599.3K
  • Earning Date
  • PRPL 03-11-2025
  • ANVS 03-31-2025
  • Dividend Yield
  • PRPL N/A
  • ANVS N/A
  • EPS Growth
  • PRPL N/A
  • ANVS N/A
  • EPS
  • PRPL N/A
  • ANVS N/A
  • Revenue
  • PRPL $504,838,000.00
  • ANVS N/A
  • Revenue This Year
  • PRPL N/A
  • ANVS N/A
  • Revenue Next Year
  • PRPL $1.83
  • ANVS N/A
  • P/E Ratio
  • PRPL N/A
  • ANVS N/A
  • Revenue Growth
  • PRPL N/A
  • ANVS N/A
  • 52 Week Low
  • PRPL $0.75
  • ANVS $2.44
  • 52 Week High
  • PRPL $2.33
  • ANVS $20.00
  • Technical
  • Relative Strength Index (RSI)
  • PRPL 49.11
  • ANVS 19.44
  • Support Level
  • PRPL $0.99
  • ANVS $2.44
  • Resistance Level
  • PRPL $1.11
  • ANVS $5.50
  • Average True Range (ATR)
  • PRPL 0.09
  • ANVS 0.32
  • MACD
  • PRPL -0.02
  • ANVS -0.15
  • Stochastic Oscillator
  • PRPL 17.46
  • ANVS 6.13

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: